Elaine H. Blais

Natasha E. Daughtrey

Robert Frederickson, III

Eric I. Abraham

Molly Grammel

Nakul Y. Shah

Kathleen McGuinness

John J. Normile

William P. Deni, Jr.

Andrea W. Jeffries

Alan E. Littmann

Charles H. Chevalier

Doug Winnard

Anthony Insogna

Lauren Abendshien

J. Brugh Lower

Lisamarie Logiudice

Jihong Lou

Sarah Geers

Shayna S. Cook

ANDA filing triggers Merck's lawsuit to protect its Bridion® drug, a surgical reversal agent, based on `6-mercapto-cyclodextrin derivative` patent claims.

Prosecution History analysis

Examiner Search analysis

Invalidity Framework analysis

Name	Ratings
Merck Sharp & Dohme BV	L5 A
Organon USA LLC	L5 A
Organon USA Inc	L5 A
Merck Sharp & Dohme LLC	L5 A

Name	Ratings
Jones Day	L5 A
John J. Normile	L3 A
Anthony Insogna	L3 B
Lisamarie Logiudice	L2 B
Sarah Geers	L1 C
Andrea W. Jeffries	L1 D
Jihong Lou	-- -- --
GibbonsLocal	L3 B
Charles H. Chevalier	L5 D
William P. Deni, Jr.	L5 E
J. Brugh Lower	L4 E
Goldman Ismail Tomaselli Brennan Baum LLP	L2 C
Alan E. Littmann	L5 A
Doug Winnard	L4 C
Lauren Abendshien	L3 D
Shayna S. Cook	-- -- --

Name	Ratings
Goodwin Procter LLP	L5 C
Robert Frederickson, III	L3 C
Elaine H. Blais	L3 D
Natasha E. Daughtrey	L2 E
Molly Grammel	L1 B
Kathleen McGuinness	L1 D
Hill Wallack LLPLocal	L3 E
Eric I. Abraham	L5 E
Nakul Y. Shah	L1 B

2:20-cv-02909

Merck Sharp & Dohme BV v. DR Reddys Laboratories Inc